Omalizumab: a new add‐on therapy for severe asthma
Authors
Abstract
Omalizumab is a new injectable antibody for use in patients with severe asthma who are poorly controlled on existing therapies. Dr Corrigan describes the clinical trial results of its efficacy and side‐effects, and explains how it is administered. Copyright © 2006 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.394 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
